LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.0016667
30.06 770.25 2736 3106 0.8808 0.8778
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
30.06 770.25 2670 3106 0.8596 0.8551
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
32.28 770.25 2935 3392 0.8651 0.8690
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
32.28 770.25 2847 3392 0.8391 0.8425
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
34.50 770.25 3138 3712 0.8454 0.8573
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
34.50 770.25 3023 3712 0.8144 0.8270
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
36.73 770.25 3402 4086 0.8326 0.8534
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
36.73 770.25 3230 4086 0.7905 0.8139
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
38.95 770.25 3674 4543 0.8086 0.8407
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
38.95 770.25 3505 4543 0.7714 0.8072
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
41.17 770.25 4004 5010 0.7991 0.8407
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
41.17 770.25 3792 5010 0.7568 0.8040
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
43.39 770.25 4243 5404 0.7851 0.8351
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
43.39 770.25 3978 5404 0.7361 0.7934
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
45.61 770.25 4581 5813 0.7881 0.8431
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
45.61 770.25 4245 5813 0.7303 0.7956
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
47.83 770.25 4820 6223 0.7745 0.8374
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
47.83 770.25 4557 6223 0.7322 0.8035
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
50.05 770.25 5187 6629 0.7824 0.8481
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
50.05 770.25 4792 6629 0.7228 0.8015
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
52.27 770.25 5525 7058 0.7827 0.8524
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
52.27 770.25 5115 7058 0.7246 0.8083
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
54.49 770.25 5893 7555 0.7800 0.8547
MN20160304_L02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
54.49 770.25 5375 7555 0.7114 0.8036
MN20160304_L02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
56.71 770.25 6253 8001 0.7815 0.8592
MN20160304_L02
K14